Schäfer, H. L., Linz, W., Falk, E., Glien, M., Glombik, H., Korn, M., . . . Rütten, H. (2012). AVE8134, a novel potent PPARα agonist, improves lipid profile and glucose metabolism in dyslipidemic mice and type 2 diabetic rats. Nature Publishing Group.
Chicago ZitierstilSchäfer, Hans Ludwig, Wolfgang Linz, Eugen Falk, Maike Glien, Heiner Glombik, Marcus Korn, Wolfgang Wendler, Andreas W. Herling, und Hartmut Rütten. AVE8134, a Novel Potent PPARα Agonist, Improves Lipid Profile and Glucose Metabolism in Dyslipidemic Mice and Type 2 Diabetic Rats. Nature Publishing Group, 2012.
MLA ZitierstilSchäfer, Hans Ludwig, et al. AVE8134, a Novel Potent PPARα Agonist, Improves Lipid Profile and Glucose Metabolism in Dyslipidemic Mice and Type 2 Diabetic Rats. Nature Publishing Group, 2012.